Methoden vergleichen
Prüfen Sie die ausgewählten Methoden nebeneinander; abweichende Zeilen sind hervorgehoben.
| Boston Aphasia Severity Rating Scale× | Voice Handicap Index× | |
|---|---|---|
| Fachgebiet | Logopädie | Logopädie |
| Familie | Process / pipeline | Process / pipeline |
| Entstehungsjahr≠ | 2001 | 1997 |
| Urheber≠ | Goodglass, H., Kaplan, E., & Barresi, B. | Jacobson, B. H., et al. |
| Typ≠ | Clinician-rated | Self-report |
| Wegweisende Quelle≠ | Goodglass, H., Kaplan, E., & Barresi, B. (2001). The Boston Diagnostic Aphasia Examination–Third Edition (BDAE-3). Philadelphia: Lippincott Williams & Wilkins. ISBN: 978-0-683-30562-9 | Jacobson, B. H., Johnson, A., Grywalski, C., Silbergleit, A., Jacobson, G., Benninger, M. S., & Newman, C. W. (1997). The Voice Handicap Index (VHI): Development and Validation. American Journal of Speech-Language Pathology, 6(3), 66–70. DOI ↗ |
| Aliasnamen≠ | BDAE, Boston Aphasia Rating Scale, Boston Aphasia Severity | VHI, VHI-30 |
| Verwandt≠ | 3 | 2 |
| Zusammenfassung≠ | The Boston Diagnostic Aphasia Examination Severity Rating Scale (BDAE-SRS) is the gold-standard clinician-administered assessment of aphasia severity and type in adults following stroke or acquired brain injury. Developed by Goodglass, Kaplan, and colleagues (2001, third edition), BDAE provides comprehensive evaluation of language across 18 domains (auditory comprehension, oral expression, naming, repetition, reading, writing) and yields both an overall severity rating (0–5 scale) and a detailed profile classifying aphasia syndrome (Broca's, Wernicke's, conduction, global, etc.). BDAE is foundational to aphasia diagnosis, prognosis, and treatment planning. | The Voice Handicap Index (VHI) is a 30-item self-report questionnaire that measures the impact of voice disorders on quality of life and functional communication. Developed by Jacobson and colleagues in 1997, it quantifies the psychosocial, physical, and emotional burden of dysphonia across functional, physical, and emotional domains. Widely used in otolaryngology and speech-language pathology to assess treatment outcomes and monitor disease progression. |
| ScholarGateDatensatz ↗ |
|
|